Pomalidomide alone or in combination with dexamethasone in Japanese patients with refractory or relapsed and refractory multiple myeloma

This phase 1, open‐label, dose‐escalation study investigated the tolerated dose (recommended dose), safety, efficacy, and pharmacokinetics of pomalidomide alone or pomalidomide plus low‐dose dexamethasone in Japanese patients with refractory or relapsed and refractory multiple myeloma. Twelve patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsue, Kosei, Iwasaki, Hiromi, Chou, Takaaki, Tobinai, Kensei, Sunami, Kazutaka, Ogawa, Yoshiaki, Kurihara, Mari, Midorikawa, Shuichi, Zaki, Mohamed, Doerr, Thomas, Iida, Shinsuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714698/
https://www.ncbi.nlm.nih.gov/pubmed/26292221
http://dx.doi.org/10.1111/cas.12772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714698/
https://www.ncbi.nlm.nih.gov/pubmed/26292221
http://dx.doi.org/10.1111/cas.12772

Ejemplares similares